Cargando…
Managing Symptom Profile of IBS-D Patients With Tritordeum-Based Foods: Results From a Pilot Study
In the past few years, increasing attention has been given to the pathologic role of specific foods in IBS, like wheat and other cereals. Recent literature describes IBS patients who may experience gastrointestinal (GI) and extra-GI symptoms precipitated by the ingestion of cereals. Tritordeum is a...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886127/ https://www.ncbi.nlm.nih.gov/pubmed/35242794 http://dx.doi.org/10.3389/fnut.2022.797192 |
_version_ | 1784660584272232448 |
---|---|
author | Russo, Francesco Riezzo, Giuseppe Linsalata, Michele Orlando, Antonella Tutino, Valeria Prospero, Laura D'Attoma, Benedetta Giannelli, Gianluigi |
author_facet | Russo, Francesco Riezzo, Giuseppe Linsalata, Michele Orlando, Antonella Tutino, Valeria Prospero, Laura D'Attoma, Benedetta Giannelli, Gianluigi |
author_sort | Russo, Francesco |
collection | PubMed |
description | In the past few years, increasing attention has been given to the pathologic role of specific foods in IBS, like wheat and other cereals. Recent literature describes IBS patients who may experience gastrointestinal (GI) and extra-GI symptoms precipitated by the ingestion of cereals. Tritordeum is a cereal of Spanish origin derived from the hybridization of durum wheat and wild barley. It is different from classic wheat for its gluten protein composition, with fewer carbohydrates and fructans and a higher content of proteins, dietary fibers, and antioxidants. This pilot study aimed to investigate the effects of a 12-week diet with Tritordeum-based foods in substitution of other cereals on the profile of GI symptoms (evaluated by appropriate questionnaire) and the health of the GI barrier (assessed by sugar absorption test and different markers of integrity and functions) in 16 diarrhea-predominant IBS (IBS-D) patients. The diet with Tritordeum-based foods (bread, bakery products, and pasta) significantly reduced IBS-D patients' symptoms. This amelioration appears to occur through an overall improvement of the GI barrier, as demonstrated by the reduced intestinal permeability and the decreased levels of markers of intestinal mucosal integrity, mucosal inflammation, and fermentative dysbiosis. |
format | Online Article Text |
id | pubmed-8886127 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88861272022-03-02 Managing Symptom Profile of IBS-D Patients With Tritordeum-Based Foods: Results From a Pilot Study Russo, Francesco Riezzo, Giuseppe Linsalata, Michele Orlando, Antonella Tutino, Valeria Prospero, Laura D'Attoma, Benedetta Giannelli, Gianluigi Front Nutr Nutrition In the past few years, increasing attention has been given to the pathologic role of specific foods in IBS, like wheat and other cereals. Recent literature describes IBS patients who may experience gastrointestinal (GI) and extra-GI symptoms precipitated by the ingestion of cereals. Tritordeum is a cereal of Spanish origin derived from the hybridization of durum wheat and wild barley. It is different from classic wheat for its gluten protein composition, with fewer carbohydrates and fructans and a higher content of proteins, dietary fibers, and antioxidants. This pilot study aimed to investigate the effects of a 12-week diet with Tritordeum-based foods in substitution of other cereals on the profile of GI symptoms (evaluated by appropriate questionnaire) and the health of the GI barrier (assessed by sugar absorption test and different markers of integrity and functions) in 16 diarrhea-predominant IBS (IBS-D) patients. The diet with Tritordeum-based foods (bread, bakery products, and pasta) significantly reduced IBS-D patients' symptoms. This amelioration appears to occur through an overall improvement of the GI barrier, as demonstrated by the reduced intestinal permeability and the decreased levels of markers of intestinal mucosal integrity, mucosal inflammation, and fermentative dysbiosis. Frontiers Media S.A. 2022-02-15 /pmc/articles/PMC8886127/ /pubmed/35242794 http://dx.doi.org/10.3389/fnut.2022.797192 Text en Copyright © 2022 Russo, Riezzo, Linsalata, Orlando, Tutino, Prospero, D'Attoma and Giannelli. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Nutrition Russo, Francesco Riezzo, Giuseppe Linsalata, Michele Orlando, Antonella Tutino, Valeria Prospero, Laura D'Attoma, Benedetta Giannelli, Gianluigi Managing Symptom Profile of IBS-D Patients With Tritordeum-Based Foods: Results From a Pilot Study |
title | Managing Symptom Profile of IBS-D Patients With Tritordeum-Based Foods: Results From a Pilot Study |
title_full | Managing Symptom Profile of IBS-D Patients With Tritordeum-Based Foods: Results From a Pilot Study |
title_fullStr | Managing Symptom Profile of IBS-D Patients With Tritordeum-Based Foods: Results From a Pilot Study |
title_full_unstemmed | Managing Symptom Profile of IBS-D Patients With Tritordeum-Based Foods: Results From a Pilot Study |
title_short | Managing Symptom Profile of IBS-D Patients With Tritordeum-Based Foods: Results From a Pilot Study |
title_sort | managing symptom profile of ibs-d patients with tritordeum-based foods: results from a pilot study |
topic | Nutrition |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886127/ https://www.ncbi.nlm.nih.gov/pubmed/35242794 http://dx.doi.org/10.3389/fnut.2022.797192 |
work_keys_str_mv | AT russofrancesco managingsymptomprofileofibsdpatientswithtritordeumbasedfoodsresultsfromapilotstudy AT riezzogiuseppe managingsymptomprofileofibsdpatientswithtritordeumbasedfoodsresultsfromapilotstudy AT linsalatamichele managingsymptomprofileofibsdpatientswithtritordeumbasedfoodsresultsfromapilotstudy AT orlandoantonella managingsymptomprofileofibsdpatientswithtritordeumbasedfoodsresultsfromapilotstudy AT tutinovaleria managingsymptomprofileofibsdpatientswithtritordeumbasedfoodsresultsfromapilotstudy AT prosperolaura managingsymptomprofileofibsdpatientswithtritordeumbasedfoodsresultsfromapilotstudy AT dattomabenedetta managingsymptomprofileofibsdpatientswithtritordeumbasedfoodsresultsfromapilotstudy AT giannelligianluigi managingsymptomprofileofibsdpatientswithtritordeumbasedfoodsresultsfromapilotstudy |